secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001933414-24-000008
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Alexander Asam not standing for re-election at 2024 annual meeting
---------------------------------------------------------------------------

- Alexander Asam, Ph.D. informed the Board on March 29, 2024 of his decision.
- He will not stand for re-election when his term expires at the 2024 annual meeting.
- Asam stated the decision was not due to any disagreement with the Company or management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341424000008/0001933414-24-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341424000008/mlys-20240329.htm
  HTML page:      https://secwatch.observer/filing/0001933414-24-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer